{"id":"NCT01555983","sponsor":"Barth Wilsey","briefTitle":"Vaporized Cannabis and Spinal Cord Injury Pain","officialTitle":"The Effect of Vaporized Cannabis on Neuropathic Pain in Spinal Cord Injury","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2012-07","primaryCompletion":"2014-08","completion":"2014-08","firstPosted":"2012-03-16","resultsPosted":"2016-01-15","lastUpdate":"2017-04-18"},"enrollment":42,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Spinal Cord Injuries","Spinal Cord Diseases"],"interventions":[{"type":"DRUG","name":"Vaporization of Cannabis","otherNames":["Medical Marijuana"]}],"arms":[{"label":"Vaporization of Cannabis 6.7% THC","type":"ACTIVE_COMPARATOR"},{"label":"Vaporization of Cannabis 2.9% THC","type":"ACTIVE_COMPARATOR"},{"label":"Vaporization of Cannabis Placebo THC","type":"PLACEBO_COMPARATOR"}],"summary":"This study will demonstrate that vaporized marijuana results in antinociception when compared to placebo in subjects with spinal cord injury. To further evaluate potential benefits and side effects, the effect of different strengths of cannabis on mood, cognition, and psychomotor performance will also be measured.","primaryOutcome":{"measure":"Number of Participants Achieving a Reduction in Pain Intensity of 30% or More","timeFrame":"hourly pain assessments for 8 hours","effectByArm":[{"arm":"Placebo THC","deltaMin":18,"sd":null},{"arm":"2.9% THC","deltaMin":26,"sd":null},{"arm":"6.7% THC","deltaMin":35,"sd":null}],"pValues":[{"comp":"OG000 vs OG001 vs OG002","p":"<.05"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["18403272","17296917","17429350","18688212","18073554"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":41},"commonTop":["orthostatic hypotension"]}}